Description
Retinalamin research peptide
Retinalamin is a complex of short polypeptides extracted from retinal tissue, developed in Russia. It is studied in ophthalmology and retinal research.
Product details
| Compound | Retinalamin |
|---|---|
| Class | Retinal polypeptide complex |
| Strength | 10mg |
| Labelling | Compound name and strength on every container |
Select your format and strength from the options above.
What Retinalamin research has examined
- Retinal cell models: photoreceptor and pigment epithelium studies.
- Peptide complexes: tissue-derived polypeptide preparations.
- Clinical research: Russian clinical studies in retinal disease.
Research interest does not establish a proven effect in humans.
Regulatory status
Retinalamin is registered as a medicine in Russia but is not approved by the FDA or EMA. The material sold here is a research chemical only.
Storage and handling
Store lyophilised vials cold, dry and away from light. Reconstitute with a suitable sterile diluent under aseptic conditions and keep solutions refrigerated. See our peptide reconstitution guide.
Related research products
Thymosin Alpha 1 RGDR · B-6 · BPC-157 Capsules · All peptides
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.